«

»

Challenges Of Developing And Facilitating Access To New Sickle Cell Disease Therapies: Case Of The Deferoxamine Patch

Black Americans who suffer from sickle cell disease face resource constraints and unique challenges associated with SCD, which include logistical hurdles such as transportation and insurance coverage. It's important to design equitable access pathways to treatments like the novel deferoxamine patch.

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive